Parkinson's disease (PD) is a neurodegenerative disorder in which inflammation and
oxidative stress play key etiopathological role. The pathology of PD brain is characterized by …

Parkinson's disease (PD) is the second most common neurodegenerative disease. The
major characteristics of PD include the loss of dopaminergic neurons in the substantia nigra …

Evidence has been accumulated showing that inflammatory and cell death pathways are
altered both in brain and periphery during Parkinson disease (PD). Neuronal loss in PD is …

Chronic microglial activation has been linked to the progressive degeneration of the
nigrostriatal dopaminergic neurons evidenced in Parkinson's disease (PD) pathogenesis …

Although, current medications for Parkinson's disease can control and relief symptoms of the
disease efficiently, they are unable to either prevent progression of the disease or maintain …

Mitogen-activated protein (MAP) kinases are a central component in signaling networks in a
multitude of mammalian cell types. This review covers recent advances on specific functions …

Parkinson's disease is a progressive neurodegenerative disorder. The classical motor
symptoms include resting tremors, bradykinesia, rigidity and postural instability and are …

Parkinson's disease (PD) is a debilitating neurodegenerative disorder causing severe motor
disabilities resulting from the loss of dopaminergic neurons in the substantia nigra pars …

Parkinson's disease (PD) is a neurodegenerative disease that primarily affects elderly
people. The mechanism on onset and progression of PD is unknown. Currently, there are no …

Parkinson's disease (PD) is one of the most debilitating brain diseases. Despite the
availability of symptomatic treatments, response towards the health of PD patients remains …